非酒精性脂肪性肝炎关键基因的鉴定及通路分析
作者: |
1陈懿,
2严丹,
1李雪,
1张友才
1 温州医科大学附属第一医院感染内科,浙江 温州 325000 2 金华市中心医院呼吸内科,浙江 金华 321000 |
通讯: |
张友才
Email: zhangyc0815@163.com |
DOI: | 10.3978/j.issn.2095-6959.2021.12.005 |
基金: | 温州市科技计划项目(Y20150016)。 |
摘要
目的:非酒精性脂肪性肝病(nonalcoholic fatty liver disease,NAFLD)是最常见的慢性肝病之一,包括非酒精性单纯性脂肪肝(nonalcoholic fatty liver,NAFL)、非酒精性脂肪性肝炎(nonalcoholic steatohepatitis,NASH)、肝硬化,最终可能发展为肝细胞癌。本研究旨在通过加权基因共表达网络分析(weighted gene co-expression network analysis,WGCNA)构建一个基因共表达网络,以探索NASH发生发展的潜在关键通路和基因。方法:数据来自基因表达综合(Gene Expression Omnibus,GEO)数据库中GSE48452和GSE89632两个数据集。使用WGCNA确定与NASH相关的模块。通过功能富集分析,探讨其潜在的生物学功能,并对这些基因进行蛋白质-蛋白质相互作用分析。结果:GSE48452数据集中的黑色模块、GSE89632数据集中的灰色模块与NASH相关最显著。基因本体(Gene Ontology,GO)富集分析显示目标基因的生物学功能分别集中在脂质降解、核染色体及有机酸的结合。京都基因与基因组百科全书(Kyoto Encyclopedia of Genes and Genomes,KEGG)通路显示基因在过氧化物酶体增殖物激活受体(peroxisome proliferator-activated receptor,PPAR)通路富集尤为显著。结论:通过WGCNA分析,确定了与NASH相关的潜在基因[脂蛋白脂肪酶(lipoprotein lipase,LPL)、胸苷酸合成酶(thymidylate synthetase,TYMS)、细胞色素P450家族26亚家族A成员1(cytochrome P450 family 26 subfamily A member 1,CYP26A1)、脂肪酸结合蛋白4(fatty acid-binding protein 4,FABP4)、脂肪酸结合蛋白5(fatty acid-binding protein 5,FABP5)、微染色体维持蛋白2(minichromosome maintenance protein 2,MCM2)、微染色体维持蛋白5(minichromosome maintenance protein 5,MCM5)、GINS复合物亚单位2(GINS complex subunit 2,GINS2)]及关键通路。这些基因可能参与NAFL到NASH的转化过程,具有一定的诊断和治疗价值。
关键词:
非酒精性单纯性脂肪肝;非酒精性脂肪性肝炎;共表达网络;基因
Identification and pathway analysis of key genes in nonalcoholic steatohepatitis
CorrespondingAuthor: Zhang Youcai Email: zhangyc0815@163.com
DOI: 10.3978/j.issn.2095-6959.2021.12.005
Foundation: This work was supported by Wenzhou Science and Technology Project, China (Y20150016).
Abstract
Objective: Nonalcoholic fatty liver disease (NAFLD) is one of the most common chronic liver diseases, including a series of pathological changes, from benign nonalcoholic fatty liver (NAFL), nonalcoholic steatohepatitis (NASH), liver cirrhosis, and finally to hepatocellular carcinoma. The purpose of this study was to construct a gene co-expression network by using weighted gene co-expression network analysis (WGCNA) to explore the potential key pathways and genes in the genesis and development of NASH. Methods: Data were collected from two data sets GSE48452 and GSE89632 in the Gene Expression Omnibus (GEO) database. WGCNA was used to identify NASH-related modules. The potential biological functions of NASH were discussed by functional enrichment analysis. These genes were analyzed with protein-protein interactions. Results: The black module in GSE48452 data set and gray module in GSE89632 data set had the most significant correlation with NASH. The enrichment analysis of Gene Ontology (GO) showed that the biological functions of the target gene focused on lipid degradation, nuclear chromosome, and organic acid binding. Kyoto Encyclopedia of Genes and Genomes (KEGG) pathway showed that genes were enriched in peroxisome proliferator-activated receptor (PPAR) pathway. Conclusion: Through WGCNA analysis, the potential genes [lipoprotein lipase (LPL), thymidylate synthetase (TYMS), cytochrome P450 family 26 subfamily A member 1 (CYP26A1), fatty acid-binding protein 4 (FABP4), fatty acid-binding protein 5 (FABP5), minichromosome maintenance protein 2 (MCM2), minichromosome maintenance protein 5 (MCM5), GINS complex subunit 2 (GINS2)] and key pathways related to NASH have been identified. These genes may be involved in the transformation process from NAFL to NASH and have certain diagnostic and therapeutic value.
Keywords:
nonalcoholic fatty liver; nonalcoholic steatohepatitis; co-expression network; gene